Filing Details
- Accession Number:
- 0001570523-18-000009
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2018-03-29 20:20:21
- Reporting Period:
- 2017-12-31
- Accepted Time:
- 2018-03-29 20:20:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1559356 | Immune Therapeutics Inc. | IMUN | Pharmaceutical Preparations (2834) | 593226705 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1570523 | Jackman Robert Dailey | 401 First Street Los Altos CA 94022 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-22 | 5,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-22 | 22,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-24 | 5,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-28 | 10,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-29 | 5,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-29 | 5,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-29 | 10,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-30 | 10,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-30 | 10,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-01 | 100,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-01 | 20,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-01 | 50,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-05 | 30,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-05 | 10,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-05 | 10,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-05 | 20,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-05 | 20,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-05 | 10,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-05 | 40,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-05 | 24,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-05 | 10,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-06 | 16,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-06 | 5,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-06 | 2,000 | $0.02 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-13 | 5,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-15 | 5,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-19 | 20,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2017-12-19 | 50,000 | $0.01 | 22,059,859 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-04 | 500 | $0.19 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-01-04 | 500 | $0.19 | 20,800,359 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Billionaire Hedge Funds
